studiedDrug

47 triples

GPTKB property

testedDrug

Subject	Object
gptkb:ROCKET_trial	gptkb:rivaroxaban
gptkb:Solidarity_trial	gptkb:remdesivir
gptkb:PACIFIC_trial	gptkb:durvalumab
gptkb:Oxygent_Clinical_Trials	Oxygent
gptkb:Solidarity_trial_(WHO)	gptkb:lopinavir/ritonavir
gptkb:IMpower150	paclitaxel
gptkb:IMpower150	gptkb:bevacizumab
gptkb:Canakinumab_Anti-inflammatory_Thrombosis_Outcomes_Study	gptkb:canakinumab
gptkb:CANTOS_trial	gptkb:canakinumab
gptkb:FOURIER_trial	gptkb:evolocumab
gptkb:Solidarity_trial_(WHO)	hydroxychloroquine
gptkb:RE-LY_trial	gptkb:dabigatran
gptkb:IMpower150	gptkb:carboplatin
gptkb:Adaptive_COVID-19_Treatment_Trial_1	placebo
gptkb:Solidarity_trial_(WHO)	gptkb:remdesivir
gptkb:SURPASS-3	gptkb:tirzepatide
gptkb:KEYNOTE-024:_Pembrolizumab_versus_Chemotherapy_for_PD-L1–Positive_Non–Small-Cell_Lung_Cancer	gptkb:pembrolizumab
gptkb:CALM_trial	gptkb:adalimumab
gptkb:Solidarity_trial	gptkb:interferon_beta-1a
gptkb:COVID-19_Solidarity_Trial_(WHO)	gptkb:lopinavir/ritonavir